ALEVIUM PHARMACEUTICALS, INC.
Patent Owner
Stats
- 3 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 16, 2010 most recent publication
Details
- 3 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 66 Total Citation Count
- Aug 10, 1998 Earliest Filing
- 10 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0317,689 Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moietyAbandonedSep 15, 07Dec 16, 10[A61K, C07D, A61P]
2010/0222,390 Methods and Compositions for the Intravenous Administration of Compounds Related to Proton Pump InhibitorsAbandonedOct 02, 09Sep 02, 10[A61K, C07D, A61P]
2010/0113,524 Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moietyAbandonedSep 15, 07May 06, 10[A61K, C07D, A61P]
2009/0048,302 Methods and compositions for the treatment of conditions related to gastric acid secretionAbandonedMar 03, 05Feb 19, 09[A61K, A61P]
2007/0293,543 THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-ZAbandonedApr 12, 07Dec 20, 07[A61K, C07D, A61P]
2007/0265,311 Therapeutic Salt Compositions and MethodsAbandonedJan 05, 07Nov 15, 07[A61K, C07D, A61P]
7294716 Process for preparing isomerically pure prodrugs of proton pump inhibitorsExpiredJul 13, 04Nov 13, 07[C07D]
2007/0161,679 Method and compositions for the intravenous administration of compounds related to proton pump inhibitorsAbandonedJan 14, 05Jul 12, 07[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.